Davis R M Inc. Acquires 9,493 Shares of Colgate-Palmolive (NYSE:CL)

Davis R M Inc. increased its stake in Colgate-Palmolive (NYSE:CLFree Report) by 6.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 147,345 shares of the company’s stock after purchasing an additional 9,493 shares during the period. Davis R M Inc.’s holdings in Colgate-Palmolive were worth $11,351,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Tucker Asset Management LLC purchased a new position in shares of Colgate-Palmolive in the first quarter valued at about $27,000. Register Financial Advisors LLC purchased a new stake in Colgate-Palmolive in the 1st quarter worth approximately $30,000. Glass Jacobson Investment Advisors llc bought a new stake in shares of Colgate-Palmolive in the 2nd quarter worth approximately $36,000. Capital Advisors Ltd. LLC raised its holdings in shares of Colgate-Palmolive by 68.0% during the second quarter. Capital Advisors Ltd. LLC now owns 692 shares of the company’s stock valued at $53,000 after acquiring an additional 280 shares in the last quarter. Finally, Larson Financial Group LLC lifted its stake in Colgate-Palmolive by 278.4% in the second quarter. Larson Financial Group LLC now owns 700 shares of the company’s stock worth $54,000 after acquiring an additional 515 shares during the period. 78.36% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In related news, VP Gregory Malcolm sold 10,493 shares of the stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $73.90, for a total transaction of $775,432.70. Following the transaction, the vice president now owns 7,852 shares of the company’s stock, valued at approximately $580,262.80. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, VP Gregory Malcolm sold 10,493 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $73.90, for a total value of $775,432.70. Following the completion of the transaction, the vice president now owns 7,852 shares in the company, valued at $580,262.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John W. Kooyman sold 3,000 shares of the business’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $75.11, for a total transaction of $225,330.00. Following the transaction, the insider now owns 5,347 shares of the company’s stock, valued at approximately $401,613.17. The disclosure for this sale can be found here. Insiders have sold a total of 93,153 shares of company stock valued at $6,851,466 over the last quarter. 0.34% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have weighed in on CL. Citigroup cut their price objective on Colgate-Palmolive from $92.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, October 11th. Bank of America reduced their target price on shares of Colgate-Palmolive from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 17th. Royal Bank of Canada upped their price objective on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock a “sector perform” rating in a report on Monday, October 30th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $85.00 to $81.00 and set an “overweight” rating for the company in a report on Thursday, October 12th. Finally, Sanford C. Bernstein cut their price target on Colgate-Palmolive from $82.00 to $76.00 in a research note on Thursday, October 12th. Five analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $82.57.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $75.47 on Tuesday. The company has a debt-to-equity ratio of 21.40, a quick ratio of 0.74 and a current ratio of 1.16. The company’s fifty day moving average price is $72.93 and its 200 day moving average price is $75.15. The stock has a market capitalization of $62.14 billion, a P/E ratio of 39.31, a P/E/G ratio of 3.35 and a beta of 0.46. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $82.09.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, October 27th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.06. Colgate-Palmolive had a return on equity of 533.40% and a net margin of 8.29%. The business had revenue of $4.92 billion for the quarter, compared to analysts’ expectations of $4.81 billion. During the same period in the previous year, the firm posted $0.74 EPS. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.21 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were issued a $0.48 dividend. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.92 annualized dividend and a yield of 2.54%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 100.00%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.